Larimar Therapeutics, Inc. Common Stock
LRMR Real Time Price USDRecent trades of LRMR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by LRMR's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
LRMR Revenue by Segment or Geography
New patents grants
-
Patent Title: Molecules for organelle-specific protein delivery Sep. 17, 2024
-
Patent Title: Methods for quantifying frataxin activity May. 21, 2024
-
Patent Title: Methods for treating myelin associated diseases and mitochondria associated diseases May. 07, 2024
-
Patent Title: Molecules for organelle-specific protein delivery Feb. 06, 2024
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to LRMR
Number of mentions of LRMR in WallStreetBets Daily Discussion
Recent picks made for LRMR stock on CNBC
ETFs with the largest estimated holdings in LRMR
|
Shareholder
|
Shares Held
|
|---|
- Who owns $LRMR stock?
- Who owns the most shares of $LRMR stock?
- What funds own $LRMR stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view LRMR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.